Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma

(2018) Mengnan Zhao et al.   Journal of Thoracic Disease

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Genetic analyses of differences between solid and nonsolid predominant lung adenocarcinomas

(2018) Jizhuang Luo et al.   Thoracic Cancer

Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registry

(2017) Xiaodong Yang et al.   JOURNAL OF SURGICAL ONCOLOGY

Growth pattern-based grading of pulmonary adenocarcinoma—Analysis of 534 cases with comparison between observers and survival analysis

(2017) J.M. Boland et al.   LUNG CANCER

The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: A meta-analysis

(2017) Hui Li et al.   PLoS One

Primary mucinous adenocarcinoma of the lung: A case report and review of the literature

(2017) Yan Liu et al.   Oncology Letters

A nomogram to predict prognosis after surgery in early stage non-small cell lung cancer in elderly patients

(2017) Fenghao Sun et al.   International Journal of Surgery

Contribution of18Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma

(2016) Zehra Dilek Kanmaz et al.   Cancer Biomarkers

Association Between Computed Tomographic Features and Kirsten Rat Sarcoma Viral Oncogene Mutations in Patients With Stage I Lung Adenocarcinoma and Their Prognostic Value

(2016) Hua Wang et al.   Clinical Lung Cancer

Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas

(2016) Ho Yun Lee et al.   Journal of Thoracic Oncology

KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung

(2016) David H. Hwang et al.   Journal of Thoracic Oncology

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

(2016) Peter Goldstraw et al.   Journal of Thoracic Oncology

The Transcriptional Repressor Polycomb Group Factor 6, PCGF6, Negatively Regulates Dendritic Cell Activation and Promotes Quiescence

(2016) Giselle M. Boukhaled et al.   Cell Reports

Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers

(2016) Ji-Hyun Lee et al.   Cell Discovery

Semiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival

(2015) Hua Wang et al.   Clinical Lung Cancer

Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung

(2015) Hyo Sup Shim et al.   Journal of Thoracic Oncology

Prognostic Comparison Between Mucinous and Nonmucinous Adenocarcinoma in Colorectal Cancer

(2015) Jong Seob Park et al.   MEDICINE

The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma

(2015) Yang Qu et al.   TUMOR BIOLOGY

KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

(2015) Mirko Marabese et al.   Oncotarget

Regulation of gene transcription by Polycomb proteins

(2015) S. Aranda et al.   Science Advances

Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma

(2014) Kyuichi Kadota et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The Relationship between TTF-1 Expression and EGFR Mutations in Lung Adenocarcinomas

(2014) Wan Shanzhi et al.   PLoS One

Pcgf6, a Polycomb Group Protein, Regulates Mesodermal Lineage Differentiation in Murine ESCs and Functions in iPS Reprogramming

(2014) D. Zdzieblo et al.   STEM CELLS

Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation

(2013) Hideomi Ichinokawa et al.   HUMAN PATHOLOGY

New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma

(2013) Naoki Yanagawa et al.   Journal of Thoracic Oncology

NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma

(2012) Tomoya Yamaguchi et al.   CANCER CELL

Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients

(2012) Akihiko Yoshizawa et al.   Journal of Thoracic Oncology